Veraxa partners with Ardigen on AI-driven cancer target selection
AI Summary
Veraxa has partnered with Ardigen to develop AI-driven cancer target selection technology, aiming to enhance precision in oncology research and drug development.
Related Articles
Oil prices surge on US-Iran attacks
Vanguard Nigeria —
Big banks poised to report booming revenue propelled by SpaceX IPO, Iran war volatility
CNBC —
Xi Jinping to attend World AI Conference for first time as China elevates tech push
South China Morning Post —
DHL launches dedicated Bangkok-Cincinnati air freight service
Container News —
South Africa’s treasury closes the money tap to force municipal accountability
The Africa Report —
Middle East premium fades – but AI boom keeps air freight rates aloft
The Loadstar —